Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7797]

Launch of the Immuno-Oncology Policy Action Framework

Launch of the Immuno-Oncology Policy Action Framework

DNA-damage causes immune reaction and inflammation and is linked to cancer development

DNA-damage causes immune reaction and inflammation and is linked to cancer development

New screening tool could speed development of ovarian cancer drugs

New screening tool could speed development of ovarian cancer drugs

Inherited gene variations tied to treatment-related hearing loss in cancer patients

Inherited gene variations tied to treatment-related hearing loss in cancer patients

$FDA approves lenvatinib for locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer$

FDA approves lenvatinib for locally recurrent or metastatic, progressive, radioactive iodine-refractory...

Short-term use of hormone replacement therapy associated with increased ovarian cancer risk

Short-term use of hormone replacement therapy associated with increased ovarian cancer risk

New drug development to focus on the genetics of cervical cancer

New drug development to focus on the genetics of cervical cancer

Order matters: Sequence of genetic mutations determines how cancer behaves

Order matters: Sequence of genetic mutations determines how cancer behaves

Abiraterone declined by Scottish Medicines Consortium for use before chemo in prostate cancer

Abiraterone declined by Scottish Medicines Consortium for use before chemo in prostate cancer

'Jekyll and Hyde' protein both prevents and spreads cancer

'Jekyll and Hyde' protein both prevents and spreads cancer

More from ecancer